1Headache Classification Committee of International Headache Society.Classifi-cation and diagnostic criteria or headache disorders, cranial neuralgias and facialpain[J].Cephalagia,1998,8(Supp17):1-96
2Bussone G,Baldini SD,Andrea G,et al.Nimodlipine versus flunarizine in commonmigraine: a controlled pilot triat[J].Headache,1987,27(2): 76-79
3Lucetti C,Nuti A, Poewese N, et al.Flunarizine in migraine prophylaxis:predictive factors for a positive response[J].Cephalalgia, 1998,18(6):349-352
4Headache Classification Committee of International Headache Society. Classification and diagnostic criteria for headache disorders cranial neuragias and facial. pain [J]. Seond Edition Cephalalgia, 2004, 24 ( Suppl 1) : 1.
5Lipton RB,Diamond S,Reed M,et al.Migraine diagnosis and treatment:results from the American Migraine Study Ⅱ.Headache,2001,41:638-645.
6Silberstein SD.Practice parameter:evidence-based guidelines for migraine headache (an evidence-based review):report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology,2000,55:754-762.
7Ferrari MD,Roon KI,Lipton RB,et al.Oral triptans (serotonin 5-HT(1B/1 D) agonists) in acute migraine treatment:a meta-analysis of 53 trials/ Lancet,2001,358:1668-1675.
8Headache Classification Subcommittee of the International Headache Society.The Internatiional Classificatiion of Headache Disorders:2nd edition.Cephalalgia,2004,24 Suppl 1:9-160.
9Lawrence EC.Diagnosis and management of migraine headaches.South Med J,2004,97:1069-1077.
10Goadsby PJ,Lipton RB,Ferrari MD.Migraine-current understanding and treatment.N Engl J Med,2002,346:257-270.
